文献速递青光眼

植入式传感器遥测非接触眼压监测用于青光眼患者:长期安全性报告与监测数据

Telemetric non-contact intraocular pressure monitoring with an implanted sensor in patients with glaucoma: long-term safety report and monitoring data.
PubMed 文献 · Br J Ophthalmol · 2022-03-21

ARGOS-01研究在2011至2012年间为6例开角型青光眼患者在 cataract 手术时将遥测眼压传感器植入睫状沟,随访至多10年,完成近25 000次眼压测量。患者对植入传感器耐受良好,未出现传感器相关不适或并发症;遥测数据可反映患者测量习惯与眼压波动,作者认为数据提示传感器长期安全性、耐受性和功能性良好,并建议进一步研究该监测方法是否有助于改善复杂青光眼患者的体验、参与度和视觉预后。

要点

  • 6例开角型青光眼患者 cataract 术中植入遥测眼压传感器,随访至多10年,完成近25 000次眼压测量。
  • 患者对植入传感器耐受良好,未报告传感器相关不适或并发症。
  • 作者认为数据提示传感器长期安全性、耐受性和功能性良好,并建议进一步研究该监测方法。

核心结论

  • 作者认为现有数据提示植入式传感器在近10年内具有良好的长期安全性、耐受性和功能性。
  • 此类传感器可能有助于促进患者自我测量眼压。
  • 作者建议进一步研究该疾病监测方法是否有助于改善复杂青光眼患者的更广泛体验、参与度和视觉预后。

研究设计与样本

  • ARGOS-01研究在2011至2012年间为6例开角型青光眼患者在 cataract 手术时将遥测眼压传感器植入睫状沟。
  • 研究报告了通过自我眼压测量、自动测量和门诊随访收集的遥测监测数据,并分析了一例随访数年的活跃患者。
  • 在剩余患者的末次访视中评估了长期安全性、耐受性和功能性。

主要发现

  • 随访期至多10年,期间完成近25 000次眼压测量。
  • 患者对植入传感器耐受良好,未出现传感器相关不适或并发症。
  • 活跃患者报告自我眼压测量操作简便,未因植入传感器而出现日常生活活动的长期限制。
  • 遥测数据可反映患者的测量习惯和眼压波动。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文指出目前可获得的长期监测数据有限。
  • 作者在结论中建议进一步研究该监测方法是否有助于改善更广泛患者的体验、参与度和视觉预后。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND/AIMS: Glaucoma is a chronic disease that requires lifelong monitoring and treatment. However, its control is limited due to discontinuous intraocular pressure (IOP) monitoring related to the practitioners' office hours. Implantable telemetric IOP sensors have made self-measurements possible and provide important information regarding the IOP profiles of patients. However, limited long-term monitoring data are currently available. METHODS: In the ARGOS-01 study, a telemetric IOP sensor was implanted in the ciliary sulcus of six patients with open-angle glaucoma during cataract surgery between 2011 and 2012. This study reports telemetric monitoring data collected by self-tonometry and automated measurements and during outpatient visits, including an analysis of one active patient with several years of follow-up. The long-term safety, tolerability and functionality were assessed in the remaining patients during the last visit. RESULTS: The follow-up period was up to 10 years, in which almost 25 000 IOP measurements were performed. The patients had excellent tolerance of the implanted sensor and did not experience sensor-related discomfort or complications. The active patient reported easy handling of self-tonometry and did not experience long-term restrictions in activities of daily living due to the implanted sensor. Telemetric data provide an insight into patients' measurement routines and IOP fluctuations. CONCLUSION: So far, our data suggest good long-term safety, tolerability and functionality of the implanted sensors up to almost ten years. Such sensors may help facilitate patients' self-measurements of IOP. This disease monitoring method should be investigated further to determine if it helps improve wider patient experience, engagement and visual prognosis for those being treated for complex glaucoma.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Schmidt I, Plange N, Walter P, et al. Telemetric non-contact intraocular pressure monitoring with an implanted sensor in patients with glaucoma: long-term safety report and monitoring data. Br J Ophthalmol. 2022. PMID: 35314512. doi:10.1136/bjophthalmol-2021-319786

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。